Reproductive health needs: comparing women at high, drug-related risk of HIV with a national sample
- PMID: 10319594
Reproductive health needs: comparing women at high, drug-related risk of HIV with a national sample
Abstract
Women who inject drugs or have injection drug-using sex partners are at high risk of acquiring human immunodeficiency virus (HIV) infection and of transmitting HIV perinatally. Many of these women need standard reproductive health care services, specialized HIV care, pre- and postnatal care, and drug treatment, but the extent of the unmet need for such health services is unknown. Large-scale national surveys that estimate drug use do not include reproductive health topics and vice versa. In addition, such surveys typically employ a household sampling method that tends not to include drug-using women. This paper presents evidence from three convenience samples that a high-risk population of women who use drugs has limited access to reproductive health services, and that this population is not represented in the National Survey of Family Growth (NSFG), the national survey that informs public policy regarding reproductive health care in the United States. Policy makers would be well served by regular surveillance of the multiple service needs of women with HIV-risk-related behaviors.
Similar articles
-
HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.MMWR Surveill Summ. 2014 Jul 4;63(6):1-51. MMWR Surveill Summ. 2014. PMID: 24990587
-
Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.MMWR Surveill Summ. 2011 Sep 2;60(11):1-20. MMWR Surveill Summ. 2011. PMID: 21881551
-
What high-risk women are telling us about access to primary and reproductive health care and HIV prevention services.AIDS Educ Prev. 1999 Dec;11(6):513-24. AIDS Educ Prev. 1999. PMID: 10693647
-
Women Who Use or Inject Drugs: An Action Agenda for Women-Specific, Multilevel, and Combination HIV Prevention and Research.J Acquir Immune Defic Syndr. 2015 Jun 1;69 Suppl 2(Suppl 2):S182-90. doi: 10.1097/QAI.0000000000000628. J Acquir Immune Defic Syndr. 2015. PMID: 25978486 Free PMC article. Review.
-
Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users.Public Health Rep. 2002;117 Suppl 1(Suppl 1):S126-34. Public Health Rep. 2002. PMID: 12435836 Free PMC article. Review.
Cited by
-
Buprenorphine use in pregnant opioid users: a critical review.CNS Drugs. 2013 Aug;27(8):653-62. doi: 10.1007/s40263-013-0072-z. CNS Drugs. 2013. PMID: 23775478 Review.
-
Health care utilization among drug-using and non-drug-using women.J Urban Health. 2002 Dec;79(4):586-99. doi: 10.1093/jurban/79.4.586. J Urban Health. 2002. PMID: 12468678 Free PMC article.
-
Chronic drug use and reproductive health care among low-income women in Miami, Florida: a comparative study of access, need, and utilization.J Behav Health Serv Res. 2003 Jul-Sep;30(3):321-31. doi: 10.1007/BF02287320. J Behav Health Serv Res. 2003. PMID: 12875099
-
Overlapping needs for sexual and reproductive health and HIV prevention in women with substance use disorders.Womens Health (Lond). 2022 Jan-Dec;18:17455065211070543. doi: 10.1177/17455065211070543. Womens Health (Lond). 2022. PMID: 35023410 Free PMC article.
-
Unintended pregnancy in opioid-abusing women.J Subst Abuse Treat. 2011 Mar;40(2):199-202. doi: 10.1016/j.jsat.2010.08.011. Epub 2010 Oct 30. J Subst Abuse Treat. 2011. PMID: 21036512 Free PMC article. Clinical Trial.